Amgen confirms it is working on a version of Alexion's drug
Amgen developing Soliris biosimilar
Amgen has started a trial of a biosimilar version of Alexion Pharmaceuticals’ Soliris (Eculizumab).
Archives for June 20, 2016
Adaptimmune inks 10-year deal with Thermo Fisher for T Cell expansion tech
Adaptimmune has entered into a new 10-year development and supply agreement for use of thermos Fisher’s Dynabeads CD3/CD28 CTS T-cell isolation, activation and expansion technology.
Japanese firms form monoclonal antibody manufacturing JV with an eye on biosims
Mitsubishi Gas Chemical and Nippon Kayaku have said they will start making monoclonal antibody drugs at a site in Niigata, Japan within two years.
Novartis to bring biomanufacturing ‘all under one roof’ with $1bn Sandoz investments
Novartis will continue investing in its manufacturing network to support a biologics pipeline which includes five new biosimilars it expects to launch by 2020.
VGXI plant expansion to support Inovio's Zika DNA vaccine development
DNA vaccines are safer and quicker to produce than egg or cell-based products, says VGXI which manufactured material for a recently approved first-in-man study of a Zika vaccine.
Scancell stops dosing in long-term trial of cancer vaccine SCIB1
Scancell Holdings has stopped dosing in a long-term extension arm of a trial of its cancer vaccine SCIB1 after discovering the product is no longer within original specification.